The Ontario Bioscience Innovation Organization (OBIO®) founded in 2009, is a not-for-proﬁt, membership based organization engaged in strategy, programming, policy development and advocacy to further the commercialization of Ontario’s human health science companies positioning Ontario as a leader in the international marketplace. OBIO advances this goal through collaborative partnerships with industry, the investment community, academia, patients and government.
2018 Paid-in-Full Members receive Additional Discount Programs with our Partners
- OBIO Benefits
- Company Benefits
- News Distribution Benefits
- Legal Services Benefits
- Industry News Benefits
- HR Benefits
OBIO is engaged in policy and government relations initiatives at the municipal, provincial and federal levels, advocating for the successful development and commercialization of bioscience and human health technologies in Ontario and Canada. The OBIO Health Science MPP Caucus, made up of Provincial politicians from all parties, meets regularly and are dedicated to the progress of the Health Science Industry. Add your voice as we communicate and promote the best interests of our members and stay up to date on the work OBIO is doing for you.
Interconnectivity builds an industry. OBIO offers industry peer-to-peer events and cross stakeholder exclusive experiences that bring executives together in the fields of industry, academia, government and the investment community. OBIO’s interconnectivity activities build industry engagement and commitment to a shared vision of a vital Health Science Sector where companies start, scale and succeed in Ontario and Canada.
OBIO programming is designed to address major issues faced by Ontario SME’s: Access to Capital and Talent. The OBIO Capital Access Advisory Program (CAAP®) and OBIO Pre-CAAP program provides strategic guidance to enhance the venture-readiness profiles of Ontario companies. The OBIO Health to Business Bridge™ H2BB™ internship program supports the development of business trained talent across Ontario‘s health science sector.